Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis

INTRODUCTION: Pasireotide (PAS) is a novel somatostatin receptor ligands (SRL), used in controlling hormonal hypersecretion in both acromegaly and Cushing’s Disease (CD). In previous studies and meta-analysis, first-generation SRLs were reported to be able to induce significant tumor shrinkage only...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondin, Alessandro, Manara, Renzo, Voltan, Giacomo, Tizianel, Irene, Denaro, Luca, Ferrari, Marco, Barbot, Mattia, Scaroni, Carla, Ceccato, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283714/
https://www.ncbi.nlm.nih.gov/pubmed/35846311
http://dx.doi.org/10.3389/fendo.2022.935759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283714/
https://www.ncbi.nlm.nih.gov/pubmed/35846311
http://dx.doi.org/10.3389/fendo.2022.935759

Ejemplares similares